Nastech Pharmaceutical Company Inc. (NSTK) Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity (BioSpace, 8 January 2008)
Nastech Pharmaceutical Company Inc. have completed the enrollment for its Phase 2 clinical trial of PYY3-36 Nasal Spray to treat obesity.
Full article